Grand Serology ELISA: Analytical Validation (Mt Sinai)
BRD ID: 3106
Tier: SOP
Source: CIMAC-CIDC Network
Number of times downloaded: 562
Description
This assay analytical validation and performance report describes the methods used to validate a standard enzyme-linked immunosorbent assay (ELISA) and grand serology assay for multiple antigens to assess a patient's serological repertoire using plasma and serum from peripheral blood and bone marrow. The document also presents data supporting the reported accuracy, precision, analytical sensitivity and specificity, and cross-site harmonization. It is used by a Cancer Immune Monitoring and Analysis Center (CIMAC) at Mount Sinai. It is a product of the CIMAC and Cancer Immunologic Data Center Network (CIMAC-CIDC Network; https://dctd.cancer.gov/research/networks/precision-medicine-oncology/cimac-cidc).
Biospecimens
FluidBlood
FluidPlasma
FluidSerum
FluidBone Marrow
Diagnoses
NeoplasticMelanoma
General
NeoplasticCarcinoma
Normal
Topics
Biospecimen Acquisition
Biospecimen Aliquots and Components
Storage
Platform-specific Methodology